LEXINGTON, Mass. (AP) _ Concert Pharmaceuticals Inc. (CNCE) on Tuesday reported a loss of $22.7 million in its first quarter.

The Lexington, Massachusetts-based company said it had a loss of 67 cents per share.

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 66 cents per share.

The biopharmaceutical company posted revenue of $5,000 in the period.

The company’s shares closed at $4.17. A year ago, they were trading at $8.36.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CNCE at https://www.zacks.com/ap/CNCE